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Abstract: Complete resection of head and neck cancers with negative surgical margins improves
the prognosis of the disease and decreases the recurrence rate. Near-infrared
fluorescence-guided surgery of head and neck cancer is a rapidly evolving field that
represents an invaluable tool for tumour detection and resection.
Here, we present a literature review of the principles of near-infrared fluorescence
imaging and its use in head and neck cancer surgery. We discuss important studies in
both animal models and humans that have been carried out up to this point. We also
outline the important fluorescent molecules and devices used in head and neck
fluorescence imaging-guided surgery.
Although near-infrared fluorescence-guided surgery for head and neck cancers
showed efficacy in animal models, its use in humans is limited by the small number of
fluorescent probes that are approved for clinical use. However, it is considered as a
novel surgical aid that helps delineate tumour margins preoperatively and could spare
patients from the added morbidity that is associated with additional surgery or
chemoradiation. In addition, it is a useful tool to detect sentinel lymph nodes as well as
metastatic lymph nodes.
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July 09, 2014 
 
 
 
RE: Resubmission of a manuscript about the role of the near-infrared fluorescence 
imaging in head and 
neck cancer surgery 
 
 
 
Dear Editor: 
 
It gives us great pleasure to resubmit to your journal our revised manuscript about the role of 
the near infrared fluorescence imaging in head and neck cancer surgery: from animal models 
to humans. We took into consideration all the modifications that we were asked to do. 
 
We would like to thank the first reviewer for his valuable comments. In reply to him: 
 
For his comment: « 1)The references are mentioned both as [1], [2), etc and also as an 
apostrophe which is something confusing and not understandable why two different methods 
are used to depict the references in one text. This should be corrected. » 
• The citation of references in the text was corrected. 
 
For his comment: « 2) In the legend of Figure 2 it is mentioned NIR, i believe it is mentioned 
to Near Infrared, please explain the Abbreviation » 
• The abbreviation was explained in the figure legend. 
 
We would like also to thank the second reviewer for his valuable comments. In reply to 
him: 
 
For his comment: «1. In a review of a new technique one would need to have some 
speculation how to compare this technique to the existing ones. There are few words 
considering autofluorescence, but nothing else. How about Lugol-staining, narrow band 
imaging and others? » 
Authors' response to reviewers' comments
• We cited the existing imaging techniques for head and neck cancer detection (red font 
colour) in the section of the principles of in vivo near-infrared fluorescence imaging. 
These techniques were compared to the role the exogenous near-infrared induced 
florescence in the management of head and neck cancer. 
 
For his comment: «2. In the principles the authors mention that the maximum depth of the 
detection is usually no more than 1cm. Yet this is claimed to be an alternative method for 
sentinel node detection. One picture shows sentinel node, but that neck is already opened. 
This needs to be clarified well. Is it possible to really see before incision all the 2 possible 
sentinel nodes in the neck like when using technetium-nanocolloid? How does 
this happen technically? » 
• We explained in the last section of the manuscript (red font colour) the advantage and 
disadvantages of the sentinel lymph node detection using the near infrared fluorescent 
imaging. We explained that in the concerned study, the sentinel lymph node was only 
detectable after exposure of the neck structures following subplatysmal flap elevation, 
which is considered as a limiting factor for the near-infrared fluorescence imaging in 
comparison to radioactive tracers that can detect sentinel lymph node preoperatively. 
We mentioned in the manuscript that we think that the relatively low depth sensitivity 
of the current generation of near infrared imaging systems should be improved in the 
near future. 
 
For his comment: « 3. In the figure legend there is fluorescent agent Angiostamp mentioned. 
What does it contain? ICG? Something else? » 
• We described in the figure 1 legend (red font colour) the structure of the commercial 
fluorescent agent Angiostamp and we explaind that it targets αvβ3 integrin. 
 
For his comment: «4. Histological pictures should be of better quality. 10 x magnification is a 
bit low to detect all the variations mentioned in the figure legend. And I didn't find an asterisk 
in figure 1h. » 
• We included histological pictures of better quality and made the asterisk in figure 1h 
clearer. 
 
Our manuscript is a literature review of the near-infrared fluorescent imaging principles and 
applications in head and neck cancer surgery. We discuss the most important studies in animal 
models and in humans that were carried out till present. We also outline the most important 
fluorescent molecules and devices used in head and neck fluorescence imaging guided 
surgery. 
 
We believe that our manuscript will make an important contribution to the medical and 
scientific literature. We chose European Archives of Oto-Rhino-Laryngology to submit our 
manuscript because it is a leading journal in both clinical and laboratory-based research on all 
aspects of head and neck tumours with a broad international readership. 
 
We certify that all authors have seen and approved the manuscript, contributed significantly to 
the work, and also that the manuscript has not been previously published nor is not being 
considered for publication elsewhere. We also certify that no writing assistance other than 
copy editing was provided in the preparation of the manuscript. All authors declare that there 
is no any conflict of interest. 
 
We hope that our manuscript will be found worthy of publication in European Archives of 
Oto-Rhino-Laryngology and we are confident that this manuscript, when accepted, will be 
widely and frequently cited for many years.  
 
Sincerely, 
 
Christian Adrien Righini, MD-PhD 
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ROLE OF NEAR-INFRARED FLUORESCENCE IMAGING IN HEAD AND NECK CANCER 
SURGERY: FROM ANIMAL MODELS TO HUMANS 
 
Dear Editor: 
 
It gives us great pleasure to resubmit to your journal our revised manuscript about the role of the near infrared 
fluorescence imaging in head and neck cancer surgery: from animal models to humans. We took into 
consideration all the modifications that we were asked to do. 
 
We would like to thank the first reviewer for his valuable comments. In reply to him: 
 
For his comment: « 1)The references are mentioned both as [1], [2), etc and also as an apostrophe which is 
something confusing and not understandable why two different methods are used to depict the references in one 
text. This should be corrected. » 
 The citation of references in the text was corrected. 
 
For his comment: « 2) In the legend of Figure 2 it is mentioned NIR, i believe it is mentioned to Near Infrared, 
please explain the Abbreviation » 
 The abbreviation was explained in the figure legend. 
 
We would like also to thank the second reviewer for his valuable comments. In reply to him: 
 
For his comment: «1. In a review of a new technique one would need to have some speculation how to compare 
this technique to the existing ones. There are few words considering autofluorescence, but nothing else. How 
about Lugol-staining, narrow band imaging and others? » 
 We cited the existing imaging techniques for head and neck cancer detection (red font colour) in the 
section of the principles of in vivo near-infrared fluorescence imaging. These techniques were 
compared to the role the exogenous near-infrared induced florescence in the management of head and 
neck cancer. 
 
For his comment: «2. In the principles the authors mention that the maximum depth of the detection is usually no 
more than 1cm. Yet this is claimed to be an alternative method for sentinel node detection. One picture shows 
sentinel node, but that neck is already opened. This needs to be clarified well. Is it possible to really see before 
incision all the 2 possible sentinel nodes in the neck like when using technetium-nanocolloid? How does 
this happen technically? » 
 We explained in the last section of the manuscript (red font colour) the advantage and disadvantages of 
the sentinel lymph node detection using the near infrared fluorescent imaging. We explained that in the 
concerned study, the sentinel lymph node was only detectable after exposure of the neck structures 
following subplatysmal flap elevation, which is considered as a limiting factor for the near-infrared 
fluorescence imaging in comparison to radioactive tracers that can detect sentinel lymph node 
preoperatively. We mentioned in the manuscript that we think that the relatively low depth sensitivity of 
the current generation of near infrared imaging systems should be improved in the near future. 
 
For his comment: « 3. In the figure legend there is fluorescent agent Angiostamp mentioned. What does it 
contain? ICG? Something else? » 
 We described in the figure 1 legend (red font colour) the structure of the commercial fluorescent agent 
Angiostamp and we explaind that it targets αvβ3 integrin. 
 
For his comment: «4. Histological pictures should be of better quality. 10 x magnification is a bit low to detect 
all the variations mentioned in the figure legend. And I didn't find an asterisk in figure 1h. » 
 We included histological pictures of better quality and made the asterisk in figure 1h clearer. 
 
All changes in the manuscript are shown in red 
 
Sincerely, 
 
The Authors 
 
 
 
Blinded Manuscript
Click here to view linked References
Abstract 
 
Complete resection of head and neck cancers with negative surgical margins improves the prognosis of the 
disease and decreases the recurrence rate. Near-infrared fluorescence-guided surgery of head and neck cancer is 
a rapidly evolving field that represents an invaluable tool for tumour detection and resection.  
 
Here, we present a literature review of the principles of near-infrared fluorescence imaging and its use in head 
and neck cancer surgery. We discuss important studies in both animal models and humans that have been carried 
out up to this point. We also outline the important fluorescent molecules and devices used in head and neck 
fluorescence imaging-guided surgery.  
 
Although near-infrared fluorescence-guided surgery for head and neck cancers showed efficacy in animal 
models, its use in humans is limited by the small number of fluorescent probes that are approved for clinical use. 
However, it is considered as a novel surgical aid that helps delineate tumour margins preoperatively and could 
spare patients from the added morbidity that is associated with additional surgery or chemoradiation. In addition, 
it is a useful tool to detect sentinel lymph nodes as well as metastatic lymph nodes. 
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probes; indocyanine green; orthotopic animal models 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Worldwide, there are 600,000 new cases of head and neck cancer and 300,000 deaths each year [1]. Surgery is 
considered one of the main treatments for head and neck cancers and it has the best overall survival rate 
compared to radiotherapy and chemotherapy. Complete resection of the tumour tissue, detection of lymph nodes 
metastases and preservation of healthy tissue during head and neck cancer surgery are major issues that strongly 
influence the patient prognosis. Additionally, these factors affect the functional and physiological integrity of the 
head and neck region with considerable impacts on multiple facets of patient life [2].  
 
The development of near-infrared optical fluorescent techniques for diagnosis, treatment and follow-up of head 
and neck cancer is a growing field that provides real-time information regarding the presence, location and 
dimensions of the cancer tissue and/or metastasis through creation of a specific contrast between normal and 
cancer tissue. This contrast could be the result of tumour-induced morphologic and biochemical alterations that 
alter optical properties of tissues and lead to tumor-specific auto-fluorescence [3]. Furthermore, fluorescence can 
be achieved through targeting head and neck tumours by fluorescent probes that bind to specific receptors on 
cancer cells.  
 
Orthotopic xenograft animal models were used to test novel applications of near-infrared fluorescence imaging-
guided surgery for head and neck cancers. Multiple studies were also performed in humans to evaluate the role 
of near-infrared fluorescence imaging guided surgery for head and neck tumours detection and resection.  
Several different fluorescent probes have been proposed to target head and neck cancers cells in animal models 
using near-infrared fluorescent imaging. For clinical translation of these results, however, very expensive and 
long lasting safety and reglementary issues should be addressed for each probe. Here, we present an overview of 
the use of near-infrared fluorescence imaging in head and neck cancer surgery in animal models and its clinical 
applications in humans. We also outline the most important fluorescent molecules and devices used in head and 
neck fluorescence imaging-guided surgery. 
 
 
Principles of in vivo near-infrared fluorescence imaging  
 
Fluorescence is a process by which molecules absorb the excitation light and re-emit light of a longer 
wavelength after a brief interval of time. Light is produced from a spectrally resolved light source such as 
filtered broadband source, light-emitting diode, or laser diode. The light emitted from the excited fluorophore is 
then captured by a charge-coupled device camera, with special care taken to filter the huge excess of photons 
coming from the excitation light. Near-infrared fluorescence imaging focuses on the detection of exogenous 
contrast agents that emit fluorescence between 700 and 900 nm. Because light is poorly absorbed by living 
tissues in this spectral window, near-infrared imaging can provide real time detection of exogenous fluorescent 
contrast agents at depths that usually do not exceed 1 cm [4-5]. In parallel, endogenous fluorescence 
(autofluorescence) imaging can also be of interest. In fact, variations in the levels and depth of endogenous 
fluorophores can be present in cancer-induced biochemical changes, such as increases in NADH, decreases in 
FAD concentration, and altered elastin and keratin compositions. It can be also related to the shielding of the 
autofluorescence of the extracellular matrix that occurs during the thickening of epithelial tissues, which occurs 
during tumour development. Consequently, autofluorescence profiles are of specific interest because changes in 
metabolic activity and cellular interactions could be reflected by spectral alteration in the fluorescence signal [6-
7]. In addition to autofluorescence, narrow band imaging (NBI) which is based on a modification of the standard 
white light spectrum by optical filters that narrow the bandwidth of transmitted light through an endoscope 
giving a blue light that penetrates less deeply into tissue, gives the operator a good resolution of superficial 
structures like submucosal vessels that could show an abnormal vasculature in early cancerous lesions [8-9]. 
Finally, other imaging techniques like lugol chromoendoscopy, confocal endoscopy, and endocytology have 
been reported to be useful for detection of early-stage head and neck squamous cell carcinoma [10]. However, 
these imaging techniques with autofluorescence and NBI are mainly used to guide biopsies and to detect 
suspicious precancerous lesions, whereas exogenous near-infrared induced florescence is used in tumour 
resection and metastasis detection [3,11-12].  
 
Head and neck cancer near-infrared fluorescent contrast agents 
 
Multiple strategies have been proposed for head and neck fluorescence imaging-guided surgery. For clinical 
translation of these strategies, pharmacokinetic studies must be performed for each fluorophore or fluorophore 
conjugate that targets specific receptors in cancer tissue. Indocyanine green (ICG) was one of the first 
fluorescent dyes tested for fluorescence imaging-guided surgery. ICG is an untargeted dye that clears from the 
tumour at a different rate than from the surrounding tissue. Because of its passive lymphatic drainage, and of its 
passive diffusion after extravasation, ICG has already shown promise for sentinel lymph node detection by 
passive targeting through its enhanced permeability and retention effect. However, its value for delineation of 
head and neck tumour margins is limited because it is considered as a blood pool agent that is not inherently 
specific for any tumour receptor [5,13-17]. For these reasons, a targeted probe would provide real-time, intra-
operative distinction of the molecular edge between cancer and adjacent normal tissue. The benefit would be to 
potentially decreasing the incidence of a positive surgical tumour margin.  
 
For clinical translation, an optimal targeted fluorescent probe should have good distribution, high affinity 
towards its target and a fast clearance from the bloodstream, to allow efficient accumulation at the tumour and 
rapid acquisition of images with high contrast [5,12-13]. One of the most important targets of fluorescent probes 
is EGFR (Epidermal Growth Factor Receptor) which is overexpressed in 80–90% of head and neck squamous 
cell carcinoma cases [18]. The Cetuximab antibody labelled with a near-infrared fluorophore is commonly used 
in head and neck fluorescence imaging-guided surgery. It is a recombinant, human/mouse chimeric monoclonal 
antibody that binds specifically to the extracellular domain of the human EGFR and is widely used in the 
treatment of head and neck squamous cell carcinoma, combined with other chemotherapeutic agents [19,18]. 
Panitumumab is another probe that targets EGFR. It is a recombinant, fully humanized monoclonal antibody that 
has the advantage of presenting lower risk of eliciting an immune response in humans than Cetuximab [19-20]. 
EGFR antibodies have also been conjugated with quantum dots, which are semiconductor nanocrystals (diameter 
1–10 nm). When coupled with fluorophores, quantum dots present the advantage of producing near-infrared 
fluorescence with strong tissue penetrating ability, low absorbance by in vivo tissue, high light stability, high 
fluorescence quantum yield and minimal interference from normal tissue autofluorescence, but they cannot be 
used for human applications because of their chemical composition [20-21]. Panitumumab and Cetuximab are 
conventional antibodies that show slow blood clearance, high accumulation in the liver and limited tumour 
penetration. Consequently, nanobodies, which are smaller functional antigen-binding fragments (15 kDa) 
derived from heavy chain antibodies, have been explored. They show highly specific binding to EGFR and 
ensure efficient distribution and tissue penetration, as well as rapid clearance from the body. When combined 
with fluorophores, they retain the ability to delineate head and neck tumours and lymph node metastases in head 
and neck cancer fluorescence imaging-guided surgery [12,22]. Finally, EGFR can be targeted by fluorophore-
labeled recombinant human EGF, but this presents the risk of EGFR receptor activation that promotes the 
malignant phenotype [23].  
 
Another target for fluorescent probes used in head and neck cancer fluorescence imaging-guided surgery, is αvβ3 
integrin, which plays an important role in cancer-associated angiogenesis, cell proliferation, migration and 
metastasis. It is widely expressed on neoendothelial cells and in some tumours including head and neck 
squamous cell carcinoma [24-26]. RAFT-c(-RGDfK-)4 (regioselectively addressable functionalized template-
arginine-glycine-aspartic acid) is a peptide-like scaffold that holds four cyclo(-RGDfK-) (cRGD) motifs. It was 
shown that this molecule targets αvβ3 integrin in vitro and in vivo and could be coupled with multiple 
fluorophores [27-32]. Like EGFR antibodies, RGD could also be coupled with quantum dots as an alternative 
way to target αvβ3 integrin in head and neck cancer fluorescence imaging-guided surgery [21].  
 
Finally, other probes showed interesting results in head and neck cancer targeting such as fluorescent 
deoxyglucose probes that detect increased glucose uptake by the glucose transporter 1 (GLUT-1), which shows 
upregulation in head and neck cancer [23,33]. VEGF was also a target of fluorescent probes comprising 
bevacizumab, which is an anti-VEGF antibody, that was conjugated to optically active fluorophores and resulted 
in adequate disease detection in the surgical setting [34]. Lastly, transferrin receptor, which is overexpressed in 
head and neck squamous cell carcinoma, was targeted using a near-infrared fluorescent transferrin conjugate that 
was able to identify and delineate head and neck tumours in mice [35]. 
 
Although head and neck cancer-specific targeting remains a challenge, numerous commercial near-infrared 
fluorophores exist. They are largely based on the cyanine chemical structure with specific modifications by each 
manufacturer. Porphyrins, squaraine, boron dipyrromethane, benzo[c]heterocycles and xanthenes are also known 
classes of near-infrared fluorophores. Fluorophores can be readily conjugated to a protein or ligand of interest for 
specific in vivo targeting through conjugation at a lysine residue or N-terminal [5,13,36].  
 
Imaging systems used in head and neck cancer fluorescence-guided surgery  
 
In addition to fluorescent contrast agents, a suitable camera system has to be developed for each application. 
Several near-infrared fluorescence imaging devices are now available for pre-clinical and clinical studies of head 
and neck fluorescence imaging-guided surgery. The FLARE™ (Frangioni Lab, Beth Israel Deaconess Medical 
Center, MA, USA) imaging system was used in animal studies, and the Mini-FLARE™ system, which is an 
optimized version for clinical studies, was used to guide sentinel lymph nodes fluorescent detection [12,17]. The 
Photodynamic Eye camera system (Hamamatsu, Germany) also showed the ability to detect lymph drainage 
pattern and sentinel lymph nodes in humans [15]. The HyperEye Medical System (Mizuho Medical Co, Ltd, 
Tokyo, Japan) has been used in fluorescent tumour delineation in humans after systemic administration of ICG, 
but no histological studies were performed on tumour margins [37]. SPY imaging system (Novadaq, Ontario, 
Canada) is another device used to image and guide head and neck cancer resection in orthotopic animal models 
[21-22]. Finally, the FluoSTIC preclinical device and the promising novel commercial fluorescence imaging 
system version, Fluostick™ (Fluoptics, Grenoble, France), are hand-held near-infrared cameras that have been 
miniaturized and optimized for oral oncologic procedures in humans [4].  
 
Use of near-infrared fluorescence imaging in head and neck cancer surgery in animal models  
 
Like any novel treatment, head and neck cancer near-infrared florescence imaging-guided surgery was first 
tested in animals before humans. Mice were the animal of choice to test this novel surgical aid because they are 
small in size, easy to handle and relatively inexpensive. Athymic nude mice were most commonly used because 
they are considered a suitable host for the development of implanted human head neck cancer cells. In addition, 
their hairlessness decreases the attenuation of the fluorescence signal emission [38]. Multiple subcutaneous and 
orthotopic mouse models of head and neck cancer were developed. The advantage of orthotopic models is that 
they provide specific interactions between cancer cells and their native environment. This can consequently 
influence molecular, pathologic and clinical features of orthotopic tumours that become representative of human 
head and neck tumours [39-41]. 
 
Near-infrared fluorescence imaging-guided surgery showed promising results for intraoperative fluorescence 
demarcation of head and neck tumours in both orthotopic and subcutaneous cell line xenografts. Tumor 
resections were performed under real-time guidance of fluorescence imaging, and there was an adequate 
correlation between the fluorescence signal and tumour extension on analysis of histological sections [42-
43,12,44,34,19,45,23]. Moreover, near-infrared fluorescence imaging in the surgical bed helped to identify 
fluorescent cancer residues that could remain unidentified if resection was performed exclusively under visual 
guidance. This had a positive impact on the recurrence-free survival rate of mice in comparison with mice that 
underwent tumour resection without any aid of fluorescence imaging (figure 1) (Atallah et al., submitted). 
Furthermore, the use of optical imaging for detection of cervical lymph node metastases showed important value 
in orthotopic mouse models in which squamous cell carcinoma metastases were found on histological sections in 
all cervical lymph nodes that showed a fluorescence signal [12,19,23,42-44]. In addition, no tumour was found 
in the negative lymph nodes on haematoxylin–eosin or immunohistochemical staining analysis [23]. Lastly, 
fluorescence imaging was used to detect distant pulmonary head and neck squamous cell carcinoma metastases. 
This could be considered an important tool in the management of head and neck cancers because distant 
metastasis is a contraindication to surgical therapy [19].  
 
Current practice and perspectives of near-infrared fluorescence imaging use in head and neck cancer 
surgery in humans 
 
One of the first applications of head and neck cancer near-infrared fluorescence imaging-guided surgery in 
humans was sentinel lymph node biopsy after peri-tumoural injection of unconjugated ICG. This showed results 
that are equivalent to radioactive tracers, without the disadvantages of the lack of real-time intraoperative visual 
information and the need for a nuclear physician [15-16,46]. Moreover, premixing ICG with human serum 
albumin (HSA) to generate ICG:HSA complexes improved the fluorescent properties and retention in the 
sentinel lymph node owing to an increased hydrodynamic diameter (figure 2) [17,47]. However, sentinel lymph 
node was only detectable after exposure of the neck structures following subplatysmal flap elevation, which is 
considered as a limiting factor for the near-infrared fluorescence imaging in comparison to radioactive tracers 
that can detect sentinel lymph node preoperatively. We think that the relatively low depth sensitivity of the 
current generation of near infrared imaging systems should be improved in the near future. ICG was also used to 
delineate head and neck tumours and lymph node metastases in humans 30 to 60 minutes after intravenous 
administration [37]. All tumours and lymphatic metastases displayed bright fluorescence emissions that clearly 
contrasted with the normal structures. Fluorescence imaging was very useful to detect metastatic lymph nodes 
that were not palpable, and not visible macroscopically, in the retropharyngeal space [37]. Precautions have to be 
taken in tumour margin demarcation using ICG because accumulation of ICG may not be limited to cancerous 
tissues. In fact, ICG would also be expected to accumulate in inflammatory tissues and areas of surgical trauma 
that could partly hamper specificity in the initial phase of enhanced permeability and retention effect. However, 
these effects occur at much lower levels and retention in tumours is greatly increased owing to defective 
architecture of lymphatic drainage [48-49]. Autofluorescence has also been used to define tumour margins, but 
the study was performed on punch biopsies of several sites from ex vivo human specimens. Sensitivity and 
specificity of the discrimination of normal tissue from cancerous tissue were evaluated by correlating 
histopathologic diagnosis with visual impression and were 91% and 86%, respectively [6].   
 
The use of head and neck cancer near-infrared fluorescence imaging-guided surgery in humans is limited by the 
small number of fluorescent probes that are approved for clinical use. Although ICG is considered a blood pool 
agent that is not inherently specific for any tumour, it is the only near-infrared fluorescent agent that has been 
used in clinical applications of head and neck cancer surgery because it is EMA (European Medicines Agency) 
and FDA (US Food and Drug Administration) approved as a near-infrared fluorescent contrast agent. 
Pharmacokinetics, pharmacodynamics and clinical toxicity studies have to be performed to analyze additional 
fluorescent probes that have shown efficient targeting of head and neck cancers in animal models. Owing to the 
complexity of the clinical translation process, we believe that repurposing of fluorescent molecules such as ICG 
and specific head and neck cancer-targeting probes such as anti-EGFR antibodies, which are already approved 
for clinical use, is a safe and cost-efficient way to develop new clinically approved fluorescent probes. In 
addition, more fluorescence imaging devices optimized for both open and endoscopic head and neck cancer 
surgery have to be developed. 
 
Conclusion 
 
Technological developments of near-infrared fluorescence imaging-guided cancer surgery have led to promising 
preclinical and clinical results. In head and neck cancer surgery, it is considered an invaluable tool to delineate 
tumours and to detect metastasis in animal models because of the real-time feedback and the contrast that it 
offers. In humans, it also showed encouraging results, but further development depends on the regulatory 
approval of near-infrared optical devices and fluorescent targeted probes for clinical use. It will certainly lead to 
significant improvements in the surgical techniques regarding optimization of tumour margins, detection of 
residual disease and identification of lymph node metastases. 
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Figure captions 
 
Fig. 1 Orthotopic tumour resection with the aid of a FluoStick™ Clinical System device after systemic injection 
of the AngioStamp™ 800 (Fluoptics, Grenoble, France). This imaging agent is a tetravalent RGD-based peptide 
(RAFT-c(-RGDfK-)4) that targets αvβ3 integrin. It is labeled with a NIR organic fluorophore with an absorbance 
and an emission maxima of 781 nm and 794 nm respectively. a) In vivo fluorescence imaging of the tumour. b) 
In vivo macroscopic appearance of the tumour. c) Ex vivo fluorescence imaging of the tumour after macroscopic 
resection without the aid of fluorescence imaging. d) Haematoxylin-eosin (H.E.) staining of the orthotopic 
tumour showing a moderately differentiated squamous cell carcinoma with disorganized architecture, 
hyperchromatic nuclei, pleomorphism, increased mitotic activity and a greatly altered nuclear-cytoplasmic ratio. 
Microscopic images were acquired under 20x magnification. e) Surgical bed after macroscopic tumour resection 
showing no residual macroscopic disease. f) Fluorescence imaging of the surgical bed showing a fluorescent 
focus that was resected under fluorescence imaging guidance. g) Ex vivo fluorescence of the fluorescent residue. 
h) H.E. staining of the fluorescent residue revealed foci of squamous cell carcinoma (asterisks) that could remain 
unidentified if resection was performed exclusively under visual guidance. Microscopic images were acquired 
under 20x magnification.  i) No residual fluorescent signal observed in the surgical bed after removal of the 
fluorescent tissue. j) The FluoStick™ Clinical System device (Fluoptics, Grenoble, France) 
 
Fig. 2 Sentinel lymph node mapping using NIR (near infrared) fluorescence imaging in oropharyngeal cancer 
patients: Peritumoural injection of 1.6 mL of 500-lM ICG:HSA identifies a SLN (arrow) in an oropharyngeal 
cancer patient. M = sternocleidomastoid muscle and S = submandibular gland. Figure reproduced, with 
permission, from Elsevier ©. Van der Vorst et al. Near-infrared fluorescence sentinel lymph node mapping of 
the oral cavity in head and neck cancer patients. Oral Oncol 2013, 9 (1):15-19 
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